Table 3 Results of the orthogonal-design L9(34) test
From: Preparation and Pharmacokinetic Study of Daidzein Long-Circulating Liposomes
Test | A | B | C/°C | D/min | Size | EE/% |
|---|---|---|---|---|---|---|
1 | 55∶40 (1) | 1:10 (1) | 60 (1) | 12 (1) | 146.9 | 80.21 |
2 | 55∶40 (1) | 1:15 (2) | 50 (2) | 24 (2) | 173.0 | 76.32 |
3 | 55∶40 (1) | 1:20 (3) | 40 (3) | 36 (3) | 184.4 | 61.25 |
4 | 65∶30 (2) | 1:10 (1) | 50 (2) | 36 (3) | 152.2 | 81.26 |
5 | 65∶30 (2) | 1:15 (2) | 40 (3) | 12 (1) | 172.6 | 73.27 |
6 | 65∶30 (2) | 1:20 (3) | 60 (1) | 24 (2) | 197.4 | 68.92 |
7 | 75∶20 (3) | 1:10 (1) | 40 (3) | 24 (2) | 159.1 | 76.37 |
8 | 75∶20 (3) | 1:15 (2) | 60 (1) | 36 (3) | 186.0 | 70.12 |
9 | 75∶20 (3) | 1:20 (3) | 50 (2) | 12 (1) | 213.1 | 64.93 |
K1 | 168.10 | 152.73 | 176.77 | 177.53 | ||
K2 | 174.07 | 177.20 | 179.43 | 176.50 | ||
K3 | 186.08 | 198.30 | 172.03 | 174.20 | ||
R | 17.97 | 45.57 | 7.40 | 3.33 |